AXSM News and Press, Axsome Therapeutics Inc. From 10/03/23

2023-10-03 05:30:00 ET Biotech stocks offer us a wide range of investing opportunities. You could buy shares of a research stage company and bet on a potential game-changing product that may launch several years from now. Or you could invest in commercial stage companies that might be about...

NEW YORK, Oct. 02, 2023 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, today announced it is joining patient advocacy organizations, including the Nat...

2023-09-25 13:08:43 ET More on Harmony Bio Seeking Alpha’s Quant Rating on Harmony Biosciences Financial information for Harmony Biosciences Harmony Biosciences: A Balancing Act As Investors Lose Some Sleep Harmony Biosciences Holdings, Inc. 2023 Q2 - ...

NEW YORK, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, today announced it is joining the global narcolepsy advocacy community, includ...

2023-09-12 06:00:00 ET Biotech stocks are a great way to grow your portfolio over time -- you can get in early on an innovator and benefit as it brings exciting candidates through the pipeline to commercialization. Of course, the drug development path isn't always smooth, so as an investor,...

Data presentations explore effects on patient-centric efficacy measures of treatments for patients with depression, and excessive sleepiness associated with obstructive sleep apnea and narcolepsy NEW YORK, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biop...

NEW YORK, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, today announced that Herriot Tabuteau, MD, Axsome’s Chief Executive Off...

2023-09-03 22:32:26 ET Summary The Fed's focus is on killing inflation, with economic and employment growth taking a backseat. The "Recessionistas" believe that a recession is imminent, but the market is still optimistic. Inflation remains stubbornly high, and progress on the ...

2023-09-01 09:29:09 ET Summary Q2 2023 earnings update shows higher than expected revenues, leading to an elevated full-year 2023 revenue forecast. Axsome Therapeutics plans to expand its sales force and utilize digital marketing strategies to reach more physicians and drive growt...

2023-08-30 08:00:00 ET Investing in stocks isn't just for the rich and famous since quality stocks can be found at almost any price. Some are trading for well above $1,000 per share, while others go for less than $100 apiece. However, finding stocks under $100 may be better for those who ar...